Hypera S.A. vs Supernus Pharmaceuticals, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Supernus Pharmaceuticals, Inc. is the larger company by market value: $2.8 B against $2.5 B for Hypera S.A., 1.1 times as much (market caps of Nov 18, 2026 for Hypera S.A. and Aug 1, 2026 for Supernus Pharmaceuticals, Inc.). Hypera S.A.'s value is an estimate (B3 São Paulo close of 18 Nov 2026 x the share count implied by the market cap reported for 01 Aug 2026). Supernus Pharmaceuticals, Inc.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
- Hypera S.A. had more revenue: $1.6 B in the year to December 2022 against $719 M for Supernus Pharmaceuticals, Inc. in the year to December 2025.
- Hypera S.A. made a net profit of $359 M, while Supernus Pharmaceuticals, Inc. made a net loss of $39 M.
- Hypera S.A. keeps more of each dollar of sales: a net margin of 22.5% against -5.4% for Supernus Pharmaceuticals, Inc.
- Hypera S.A. employs more people: 9,000 against 575 at Supernus Pharmaceuticals, Inc. Each employee brings in about $177,222 of revenue at Hypera S.A. and $1,250,348 at Supernus Pharmaceuticals, Inc.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Hypera S.A. HYPE3.SA · #5,585 in the world | Supernus Pharmaceuticals, Inc. SUPN · #5,225 in the world |
|---|---|---|
| Profile | ||
| Country | 🇧🇷 Brazil | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceutical | Pharmaceutical |
| Founded | 2001 | — |
| Size | ||
| Market cap | $2.5 B | $2.8 B |
| Revenue | $1.6 B | $719 M |
| Net income | $359 M▲ best | $-39 M |
| Employees | 9,000 | 575 |
| Valuation | ||
| P/E ratio | 7.0× | — |
| Price to sales | 1.6× | 3.2× |
| Price to book | 1.1× | 2.6× |
| Free cash flow yield | — | 1.6% |
| Profitability | ||
| Gross margin | — | 89.6% |
| Operating margin | — | -8.7% |
| Net margin | — | -5.4% |
| Return on equity | — | -3.7% |
| Growth | ||
| Revenue growth | — | 8.6% |
| Revenue growth, 3 years a year | — | 2.5% |
| Cash | ||
| Free cash flow margin | — | 6.4% |
| Altman Z-score zone | — | safe |
| Data as of | Market cap Nov 2026 | Market cap Aug 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Hypera S.A. or Supernus Pharmaceuticals, Inc.?
Supernus Pharmaceuticals, Inc. is the larger company by market value: $2.8 B against $2.5 B for Hypera S.A., 1.1 times as much (market caps of Nov 18, 2026 for Hypera S.A. and Aug 1, 2026 for Supernus Pharmaceuticals, Inc.). Hypera S.A.'s value is an estimate (B3 São Paulo close of 18 Nov 2026 x the share count implied by the market cap reported for 01 Aug 2026). Supernus Pharmaceuticals, Inc.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
Which makes more money, Hypera S.A. or Supernus Pharmaceuticals, Inc.?
Hypera S.A. had more revenue: $1.6 B in the year to December 2022 against $719 M for Supernus Pharmaceuticals, Inc. in the year to December 2025. Hypera S.A. made a net profit of $359 M, while Supernus Pharmaceuticals, Inc. made a net loss of $39 M.
Which is more profitable, Hypera S.A. or Supernus Pharmaceuticals, Inc.?
Hypera S.A. keeps more of each dollar of sales: a net margin of 22.5% against -5.4% for Supernus Pharmaceuticals, Inc.
Which has more employees, Hypera S.A. or Supernus Pharmaceuticals, Inc.?
Hypera S.A. employs more people: 9,000 against 575 at Supernus Pharmaceuticals, Inc. Each employee brings in about $177,222 of revenue at Hypera S.A. and $1,250,348 at Supernus Pharmaceuticals, Inc.
More about Hypera S.A.
More about Supernus Pharmaceuticals, Inc.
- Supernus Pharmaceuticals, Inc.: company page
- Who owns Supernus Pharmaceuticals, Inc.?
- Supernus Pharmaceuticals, Inc. market cap history
- Supernus Pharmaceuticals, Inc. revenue by year
- Is Supernus Pharmaceuticals, Inc. cheap or expensive?
- Supernus Pharmaceuticals, Inc. against its peers: ranks and percentiles
Sources#
Every figure on this page comes from these, with the date shown next to it.